Last Week in GER Research: API/Sigma, M1, Eclipx/Mcmillan and Hansoh IPO
In this version of the GER weekly research wrap, we assess the bump prospects in the Australian Pharma Industries (API AU) / Sigma Healthcare (SIG...
585 Views
Sigma Healthcare Market Update:Â Strategic Review Expects More
In my first insight on this potential deal situation in December API Tilts at Sigma Healthcare: Expect More, I noted that despite the 69% premium...
531 Views
API/Sigma Merger: Sigma’s Hand Strengthens to Improve the Terms of API’s Bid
Today, Sigma Healthcare (SIG AU)Â announced the results of its four-month-long strategic review. As a reminder, on 14 December, Australian Pharma...
544 Views
The GER Weekly EVENTS Wrap: Anta/Amer, Trade Me, Hengan and API/Sigma
Below is a recap of the key event-driven research produced by the Global Equity Research team. This week Arun develops a differentiated view on the...
545 Views
API/Sigma Merger: Sigma Shareholders Need a Better Offer
Australian Pharma Indus (API AU), a pharmaceutical wholesaler, has lobbed an indicative cash-scrip proposal for its competitor, Sigma Healthcare...
553 Views